1
Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)
Condition(s):Acute GVHDLast Updated:November 27, 2020Not yet recruiting
Tacrolimus: 1477 Clinical Trials, Page 1 of 148
Hide Studies Not Open or Pending
2
Tacrolimus Treatment for Refractory Autoimmune Cytopenia
Condition(s):Autoimmune Hemolytic Anemia; Pure Red Cell Aplasia; Evans SyndromeLast Updated:December 3, 2019Recruiting
3
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
Condition(s):Transplant;Failure,KidneyLast Updated:March 31, 2020Recruiting
4
Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant
Condition(s):Heart Transplant Failure and RejectionLast Updated:November 3, 2020Recruiting
5
OPTImization of the Dose of tacroliMUS by Bayesian Prediction
Condition(s):KIDNEY TRANSPLANTATIONLast Updated:January 8, 2021Completed
6
Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells
Condition(s):HemochromatosisLast Updated:September 4, 2018Completed
7
Tacrolimus Treatment for Refractory PRCA
Condition(s):Pure Red Cell AplasiaLast Updated:May 30, 2018Unknown status
8
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
Condition(s):Kidney Transplantation; Pancreas Transplantation; DiabetesLast Updated:September 29, 2020Recruiting
9
Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome
Condition(s):Dry Eye; Sjogren SyndromeLast Updated:May 22, 2019Completed
10
Population Pharmacokinetics of Tacrolimus in Nephrotic Syndrome
Condition(s):Nephrotic Syndrome; Tacrolimus; PharmacokineticsLast Updated:August 5, 2019Not yet recruiting